The bronchopulmonary (BP) and gastroenteropancreatic (GEP) organ systems harbor the
majority of the neuroendocrine neoplasms (NENs) of the body, comprising 20 and 70% of all …

The recent classifications of lung and digestive neuroendocrine neoplasms (NENs) make a
fundamental distinction between well-and poorly-differentiated neoplasms. Well …

Neuroendocrine neoplasms (NEN) appear homogeneous in terms of morphology, but
constitute a very heterogeneous group of tumors in terms of biological and clinical features …

Neuroendocrine neoplasms (NENs) can develop in almost any organ and span a spectrum
from well-differentiated and indolent neuroendocrine tumours (NETs) to poorly differentiated …

Abstract Purpose of Review Classification and nomenclature of neuroendocrine neoplasms
(NEN) have frequently changed over the last years. These changes reflect both increasing …

The tumours of the disseminated/diffuse neuroendocrine cell system are a group of
neoplasms sharing uniformly appearing cells which differ from each other in their biology …

In the last two decades, the increasing availability of technologies for molecular analyses
has allowed an insight in the genomic alterations of neuroendocrine neoplasms (NEN) of …

High-grade neuroendocrine neoplasms (HG-NENs) are clinically aggressive diseases, the
classification of which has recently been redefined. They now include both poorly …

Gastroenteropancreatic (GEP) neuroendocrine neoplasms (NENs) are heterogeneous
regarding site of origin, biological behavior, and malignant potential. There has been a rapid …

Neuroendocrine tumours (NET) of the gastrointestinal tract and the lung are a rare and
heterogeneous group of tumours. The molecular characterization and the clinical …